Clover Corporation Limited (ASX: CLV)

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

Clover Corporation Limited

ASX:
CLV

Clover Corp. Ltd. engages in research and product development of functional food and infant nutrition ingredients. It also focuses on the sale of natural oils and production of encapsulated powders. Its products include Docosahexaenoic acid oils and powders, and Microencapsulation. The company was founded by Guy Hamish Drummond in 1988 and is headquartered in Sydney, Australia.

Stock Performance Profile:

(Source: TradingView) 3-Month Performance Profile of CLV compared to ASX 200.

5-Year Financial Snapshot:

(Data Source: TradingView. Graphic Source: Pristine Gaze)

Following a period of financial decline in recent years, Clover Corporation has demonstrated encouraging signs of recovery in the first half of fiscal year 2025. The company reported revenue of $37.6 million, representing a 37% year-on-year increase, alongside a marked improvement in earnings, which rose to $2.37 million from a loss of approximately $600,000 in the prior corresponding period. These results reflect a meaningful turnaround in operational performance and indicate promising financial momentum moving forward.

Relative Strength Index (RSI) Analysis:


Hourly Time-Frame (HTF)

(Graphic Source: TradingView)

Clover Corporation currently exhibits a robust Relative Strength Index (RSI) of 58.25 on the hourly chart, indicating solid buying momentum in the short term. This technical position suggests the stock is experiencing an active upward trend, with market sentiment remaining constructive and potentially supportive of continued price appreciation in the near future.


Daily Time-Frame (DTF)

(Graphic Source: TradingView)

Clover Corporation also maintains a stable RSI of 54.43 on the daily chart, reflecting sustained investor interest and balanced market conditions. A comparable upward trajectory on the weekly timeframe further reinforces the presence of steady buying momentum and supports a broadly bullish sentiment toward the stock. These technical indicators suggest a favorable outlook for the security across both short-term and longer-term horizons.

Support & Resistance Analysis:

(Graphic Source: TradingView) Clover Corporation Limited (ASX: CLV) Daily Time-Frame (DTF) Chart.

Clover is currently trading within a well-defined range between key support and resistance levels. Following an extended period of consolidation near the $0.43 support level, the stock has recently demonstrated a notable upward rally. While some short-term resistance may be encountered in the near term, the next significant resistance level is around $0.53. This gap offers considerable upside potential, indicating that, should bullish momentum persist, Clover could continue to appreciate meaningfully in the coming sessions.

Bollinger Bands Analysis:

(Graphic Source: TradingView) Clover Corporation Limited (ASX: CLV) Daily Time-Frame (DTF) Chart.

Clover has recently broken above its short-term Simple Moving Average (SMA), which also represents the middle band of the Bollinger Bands on the weekly chart—signaling a promising and sustained uptrend over a longer timeframe. This technical breakout reflects strengthening bullish momentum. With the stock now trending above this key average, it is well-positioned to continue appreciating toward its upper Bollinger Band near the $0.53 level. This target aligns with broader resistance levels, reinforcing the potential for further upside if positive momentum continues.

Analyst’s Take:

Clover, despite experiencing a notable financial downturn in recent years, now displays strong potential for a meaningful recovery in FY25. This is evidenced by substantial improvements during the first half of the fiscal year, with revenues up 37% year-over-year to $37.6 million and a turnaround to $2.37 million in earnings from prior losses. These developments suggest the company may return to the healthier financial levels seen in 2022 and 2023. Despite these encouraging fundamentals, market sentiment remains subdued, resulting in a highly attractive valuation. The stock is currently trading at a P/E ratio of just 17x—well below its historical range of 30x to 50x—indicating significant upside potential as sentiment improves and financial recovery gains momentum.

As per Pristine Gaze, you may consider a “Buy” on “Clover Corporation Limited” at the closing price of “$0.465” (As of 21 May 2025).

 

*All currency figures are in Australian Dollars unless stated otherwise.

*All data sourced from Company Reports and TradingView.

Disclaimer

The reports provided by Pristine Gaze are designed to deliver general financial insights, including stock and sector market analysis and investment commentary. These reports aim to support informed decision-making but are strictly intended for informational purposes. They do not constitute personalized financial advice and should not be relied upon as such. The information provided does not take into account individual investment objectives, financial circumstances, or specific needs.

General Advice Warning: The insights and recommendations offered in Pristine Gaze reports are of a general nature and are not tailored to any individual investor’s circumstances. Investment decisions are highly personal and depend on many factors, including but not limited to financial goals, risk tolerance, and current financial standing. We strongly advise consulting a qualified financial advisor who can evaluate your unique situation and provide professional guidance tailored to your needs before acting on any information contained in these reports.

Past Performance: Historical data, including past performance metrics of securities or markets mentioned in these reports, should not be regarded as an accurate indicator of future results. The financial markets are subject to significant variability, and past success does not guarantee similar outcomes in the future. It is essential to recognize that external factors, including but not limited to economic conditions, regulatory changes, and market dynamics, can greatly influence future performance and results.

Forward-Looking Statements: Certain projections and forecasts presented in Pristine Gaze reports may include forward-looking statements based on assumptions and expectations about future market conditions. These statements are speculative and inherently uncertain, as they depend on variables that may not materialize as anticipated. Factors such as economic conditions, market trends, policy changes, and unforeseen events can significantly impact these projections. Investors should approach forward-looking statements with caution and recognize the associated risks.

Data Accuracy: All financial data, metrics, and projections contained in our reports are derived from publicly available company filings, credible industry reports, and verified sources. While Pristine Gaze endeavors to ensure the accuracy, timeliness, and reliability of the information provided, we cannot guarantee its completeness or precision. Market conditions and company policies may evolve, leading to changes in the relevance of the data presented. The content of our reports may be updated or modified without prior notice.

Technical Analysis: Reports may include discussions of technical indicators, such as Relative Strength Index (RSI), Bollinger Bands, or moving averages. These indicators are tools used to analyze market trends but are inherently speculative and subject to interpretation. They do not provide definitive predictions about future price movements and should not be relied upon as sole determinants of investment decisions. Investors should combine technical analysis with other forms of research and risk assessment.

Dividend Yield: References to dividend payments or yields are based on historical data and the current financial policies of the companies discussed. Dividends are not guaranteed and may fluctuate depending on the financial performance of the company, market conditions, and regulatory requirements. Investors should consider these variables and the potential for dividend changes when evaluating dividend-paying securities.

Liability Disclaimer: Pristine Gaze, along with its directors, employees, associates, and affiliates, assumes no responsibility or liability for any losses or damages incurred due to reliance on the information or recommendations contained in our reports. This disclaimer applies to all forms of losses, including but not limited to direct, indirect, incidental, or consequential losses. Investors are hereby advised to conduct their independent research and seek professional advice before making investment decisions.

Third-Party Data and Links: some reports may reference external data, include hyperlinks to third-party websites, or incorporate information from other sources. While we aim to use credible and reliable references, Pristine Gaze does not endorse or take responsibility for the accuracy or reliability of external content. Users are advised to evaluate third-party information critically and acknowledge the risks of using such data.

Intellectual Property: All content within Pristine Gaze reports, including but not limited to text, graphics, designs, methodologies, and analyses, is the exclusive intellectual property of Pristine Gaze Pty Ltd. This content is protected under Australian and international copyright and trademark laws. Unauthorized reproduction, modification, or distribution of any part of the content without prior written consent from Pristine Gaze is strictly prohibited. Legal action may be pursued in the case of infringement.

Terms and Policies: For additional information regarding the terms and conditions of our services, our approach to data privacy, and the scope of our financial advice, please refer to our Terms and Conditions, Privacy Policy, and Financial Services Guide, which are available on our official website. 

XRF Scientific Limited (ASX: XRF)

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

XRF Scientific Limited

ASX:
XRF

XRF Scientific Ltd. manufactures and markets precious metal products, specialized chemicals and instruments for the scientific and analytical industries. It operates through the following segments: Capital Equipment, Precious Metals, and Consumables. The Capital Equipment segment engages in the design, manufacture and service organization, specialized in automated fusion equipment, high temperature test and production furnaces, as well as general laboratory equipment. The Precious Metals segment manufactures products for the laboratory and platinum alloy markets. The Consumables segment produces and distributes consumables, chemicals and other supplies for analytical laboratories. The company was founded in 1972 and is headquartered in Osborne Park, Australia.

Stock Performance Profile:

(Source: TradingView) 3-Month Performance Profile of XRF compared to ASX 200.

5-Year Financial Snapshot:

(Data Source: TradingView. Graphic Source: Pristine Gaze)

The company has demonstrated impressive and consistent financial growth over the past five years, with revenue increasing from $29 million in 2020 to $59 million in 2024—more than doubling over the period. Net income also showed substantial improvement, rising from $3.12 million to $8.89 million, reflecting efficient cost management and scalable operations. Additionally, operating cash flows strengthened from $4.2 million to $8.09 million, reinforcing the company’s robust financial health and operational efficiency. This sustained performance highlights the firm’s strong growth trajectory and provides a solid foundation for continued expansion and value creation in the years ahead.

Relative Strength Index (RSI) Analysis:


Hourly Time-Frame (HTF)

(Graphic Source: TradingView)

The security’s Relative Strength Index (RSI) of 58.22 on the hourly timeframe reflects solid bullish momentum, indicating sustained buying interest in the near term. This level suggests the stock is not yet overbought but is experiencing strong upward price action, supported by positive market sentiment. The current RSI positioning reinforces the likelihood of continued short-term upside, particularly if momentum persists and is supported by broader technical or fundamental catalysts.


Daily Time-Frame (DTF)

(Graphic Source: TradingView)

The security’s Relative Strength Index (RSI) of 41.58 reflects a notable recovery from oversold territory, suggesting improving momentum and a potential trend reversal. This rebound indicates strengthening investor confidence and supports the case for a mid-term recovery. If sustained, the improving RSI trend could also lay the foundation for considerable long-term upside.

Support & Resistance Analysis:

(Graphic Source: TradingView) XRF Scientific Limited (ASX: XRF) Daily Time-Frame (DTF) Chart.

XRF is currently trading near a key support level at $1.49, which helps limit downside risk and provides a solid base for potential price appreciation. The next significant resistance lies at approximately $1.79, offering substantial upside potential. A sustained breakout beyond this level could see the stock testing the $1.90 zone, further enhancing the bullish outlook. With a favorable risk-to-reward profile estimated between 3:1 and 5:1, the setup appears highly attractive for tactical investors seeking asymmetric return opportunities.

Bollinger Bands Analysis:

(Graphic Source: TradingView) XRF Scientific Limited (ASX: XRF) Daily Time-Frame (DTF) Chart.

The security recently breached and closed below its lower Bollinger Band—often a signal of potential short-term trend exhaustion. However, a prompt re-entry into the bands, coupled with the price now approaching the mid-band (typically the 20-period EMA), indicates weakening bearish momentum. This behavior suggests a potential short-term trend reversal, reinforced by diminishing selling pressure near the lower band. Additionally, the current healthy Bollinger Band width reflects elevated volatility, which may support an upcoming directional move as momentum builds.

Analyst’s Take:

XRF Scientific has demonstrated a strong financial growth trajectory in recent years, consistently achieving record highs in revenue, earnings, and operating cash flows. This solid operational performance underscores the company’s robust fundamentals and long-term value proposition. However, recent market sentiment has turned negative, driven largely by external macroeconomic concerns—particularly uncertainty around U.S. trade policies and tariff implications, such as the Trump-era tariffs. Despite these headwinds, the current technical setup—supported by multiple indicators across various timeframes—suggests a favorable environment for a potential recovery.

As per Pristine Gaze, you may consider a “Buy” on “XRF Scientific Limited” at the closing price of “$1.54” (As of 7 May 2025).

 

*All currency figures are in Australian Dollars unless stated otherwise.

*All data sourced from Company Reports and TradingView.

Disclaimer

The reports provided by Pristine Gaze are designed to deliver general financial insights, including stock and sector market analysis and investment commentary. These reports aim to support informed decision-making but are strictly intended for informational purposes. They do not constitute personalized financial advice and should not be relied upon as such. The information provided does not take into account individual investment objectives, financial circumstances, or specific needs.

General Advice Warning: The insights and recommendations offered in Pristine Gaze reports are of a general nature and are not tailored to any individual investor’s circumstances. Investment decisions are highly personal and depend on many factors, including but not limited to financial goals, risk tolerance, and current financial standing. We strongly advise consulting a qualified financial advisor who can evaluate your unique situation and provide professional guidance tailored to your needs before acting on any information contained in these reports.

Past Performance: Historical data, including past performance metrics of securities or markets mentioned in these reports, should not be regarded as an accurate indicator of future results. The financial markets are subject to significant variability, and past success does not guarantee similar outcomes in the future. It is essential to recognize that external factors, including but not limited to economic conditions, regulatory changes, and market dynamics, can greatly influence future performance and results.

Forward-Looking Statements: Certain projections and forecasts presented in Pristine Gaze reports may include forward-looking statements based on assumptions and expectations about future market conditions. These statements are speculative and inherently uncertain, as they depend on variables that may not materialize as anticipated. Factors such as economic conditions, market trends, policy changes, and unforeseen events can significantly impact these projections. Investors should approach forward-looking statements with caution and recognize the associated risks.

Data Accuracy: All financial data, metrics, and projections contained in our reports are derived from publicly available company filings, credible industry reports, and verified sources. While Pristine Gaze endeavors to ensure the accuracy, timeliness, and reliability of the information provided, we cannot guarantee its completeness or precision. Market conditions and company policies may evolve, leading to changes in the relevance of the data presented. The content of our reports may be updated or modified without prior notice.

Technical Analysis: Reports may include discussions of technical indicators, such as Relative Strength Index (RSI), Bollinger Bands, or moving averages. These indicators are tools used to analyze market trends but are inherently speculative and subject to interpretation. They do not provide definitive predictions about future price movements and should not be relied upon as sole determinants of investment decisions. Investors should combine technical analysis with other forms of research and risk assessment.

Dividend Yield: References to dividend payments or yields are based on historical data and the current financial policies of the companies discussed. Dividends are not guaranteed and may fluctuate depending on the financial performance of the company, market conditions, and regulatory requirements. Investors should consider these variables and the potential for dividend changes when evaluating dividend-paying securities.

Liability Disclaimer: Pristine Gaze, along with its directors, employees, associates, and affiliates, assumes no responsibility or liability for any losses or damages incurred due to reliance on the information or recommendations contained in our reports. This disclaimer applies to all forms of losses, including but not limited to direct, indirect, incidental, or consequential losses. Investors are hereby advised to conduct their independent research and seek professional advice before making investment decisions.

Third-Party Data and Links: some reports may reference external data, include hyperlinks to third-party websites, or incorporate information from other sources. While we aim to use credible and reliable references, Pristine Gaze does not endorse or take responsibility for the accuracy or reliability of external content. Users are advised to evaluate third-party information critically and acknowledge the risks of using such data.

Intellectual Property: All content within Pristine Gaze reports, including but not limited to text, graphics, designs, methodologies, and analyses, is the exclusive intellectual property of Pristine Gaze Pty Ltd. This content is protected under Australian and international copyright and trademark laws. Unauthorized reproduction, modification, or distribution of any part of the content without prior written consent from Pristine Gaze is strictly prohibited. Legal action may be pursued in the case of infringement.

Terms and Policies: For additional information regarding the terms and conditions of our services, our approach to data privacy, and the scope of our financial advice, please refer to our Terms and Conditions, Privacy Policy, and Financial Services Guide, which are available on our official website.